Compare · NUS vs WGRX
NUS vs WGRX
Side-by-side comparison of Nu Skin Enterprises Inc. (NUS) and Wellgistics Health Inc. (WGRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NUS and WGRX operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- NUS carries a market cap of $195.9M.
- Over the past year, NUS is down 58.6% and WGRX is down 88.2% - NUS leads by 29.7 points.
- WGRX has been more active in the news (10 items in the past 4 weeks vs 5 for NUS).
- NUS has more recent analyst coverage (4 ratings vs 0 for WGRX).
- Company
- Nu Skin Enterprises Inc.
- Wellgistics Health Inc.
- Price
- -
- -
- Market cap
- $195.9M
- -
- 1M return
- -23.23%
- +2.47%
- 1Y return
- -58.55%
- -88.20%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- 1996
- 2025
- News (4w)
- 5
- 10
- Recent ratings
- 4
- 0
Nu Skin Enterprises Inc.
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Latest NUS
- SEC Form 10-Q filed by Nu Skin Enterprises Inc.
- CORRECTING and REPLACING Nu Skin Enterprises Reports Third Quarter Earnings
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Nu Skin Enterprises Reports Third Quarter Earnings
- Nu Skin Enterprises Announces Quarterly Dividend
- Nu Skin Enterprises to Announce Third Quarter 2026 Financial Results
- Director Woodbury Edwina D was granted 22 shares, increasing direct ownership by 0.04% to 62,474 units (SEC Form 4)
- Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Nu Skin Enterprises Inc.
Latest WGRX
- SEC Form PRE 14C filed by Wellgistics Health Inc.
- SEC Form 424B5 filed by Wellgistics Health Inc.
- Wellgistics Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form 10-Q filed by Wellgistics Health Inc.
- Wellgistics Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form SCHEDULE 13G filed by Wellgistics Health Inc.
- Amendment: SEC Form S-1/A filed by Wellgistics Health Inc.
- SEC Form DEF 14C filed by Wellgistics Health Inc.
- Wellgistics Health Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 8-K filed by Wellgistics Health Inc.